Literature DB >> 12413940

GRK3 regulation during CRF- and urocortin-induced CRF1 receptor desensitization.

Frank M Dautzenberg1, Sandra Wille, Sandra Braun, Richard L Hauger.   

Abstract

The EC(50) values for concentration-dependent stimulation of cAMP accumulation by CRF (1.3nM) and urocortin (1.0nM) were equivalent in human retinoblastoma Y79 cells. The time course and magnitude of CRF- and urocortin-induced CRF(1) receptor desensitization were similar. A significant 3-fold increase in GRK3, but not GRK2, mRNA levels accompanied the emergence of CRF(1) receptor desensitization in Y79 cells exposed to CRF. In preliminary experiments, retinoblastoma GRK3 protein expression became upregulated during a 48-h CRF exposure. Neither GRK3 nor GRK2 expression increased in Y79 cells exposed to urocortin for 10 min to 48 h. We hypothesize that GRK3 upregulation may be a cellular negative feedback process directed at maximizing CRF(1) receptor desensitization by heightening GRK3 phosphorylating capacity during prolonged exposure to high CRF. Regulation of GRK expression associated with urocortin- and CRF-induced CRF(1) receptor desensitization appears to differ, despite a similar level of signaling via the cAMP-protein kinase A pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12413940     DOI: 10.1016/s0006-291x(02)02463-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Frank M Dautzenberg; James B Lohr; Sandra Braun; Robert H Oakley
Journal:  Neuropharmacology       Date:  2011-11-25       Impact factor: 5.250

Review 2.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

3.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

Review 4.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 5.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

6.  Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain.

Authors:  H Berger; N Heinrich; D Wietfeld; M Bienert; M Beyermann
Journal:  Br J Pharmacol       Date:  2006-10-23       Impact factor: 8.739

Review 7.  Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

Authors:  Richard L Hauger; Victoria Risbrough; Robert H Oakley; J Alberto Olivares-Reyes; Frank M Dautzenberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

8.  Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.

Authors:  Michael J McCarthy; Thomas B Barrett; Stephanie Nissen; John R Kelsoe; Eric E Turner
Journal:  J Psychiatr Res       Date:  2009-09-18       Impact factor: 4.791

9.  Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling.

Authors:  Karl Balabanian; Angélique Levoye; Lysiane Klemm; Bernard Lagane; Olivier Hermine; Julie Harriague; Françoise Baleux; Fernando Arenzana-Seisdedos; Françoise Bachelerie
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.